
MSD has entered a research collaboration with biopharma company Complix, using the company’s proprietary technology to develop new treatments for …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

